MedCity News
JULY 7, 2024
As a result of ever-growing cybersecurity threats, health systems are prioritizing the role of the chief information security officer, according to a consultant at WittKieffer. The post Can Health Systems Afford to Overlook the CISO Role? appeared first on MedCity News.
pharmaphorum
JULY 7, 2024
Novartis, Pfizer, Otsuka and Novo Nordisk have been called out for breaching the ABPI code of practice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JULY 7, 2024
In this episode, we’re joined by Rabia Muqaddam, senior staff attorney at the Center for Reproductive Rights. Muqaddam discusses the Supreme Court’s recent decision that preserved access to the abortion pill mifepristone. The post MedCity FemFwd: The Supreme Court’s Decision on Mifepristone appeared first on MedCity News.
Clarivate
JULY 7, 2024
The New Active Substance Work-Sharing Initiative (NASWSI), or “Access” for simplicity, allows regulatory authorities (RAs) of countries that are part of the Access Consortium (Australia, Canada, Singapore, Switzerland, and the UK) to jointly review applications for the registration of new active substances or new indications. The Access Consortium is a coalition of medium-sized RAs that aims to maximize international co-operation, reduce duplications, and increase RAs’ capacity to ensure timely
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
MedCity News
JULY 7, 2024
Through a new partnership, Highmark is integrating Laguna’s conversational AI technology into the insurer’s platform to support care managers. The post Highmark Taps Laguna for Conversational AI appeared first on MedCity News.
Pharmacy Times
JULY 7, 2024
In the 2 mg bulevirtide (Gilead Sciences) group, 44% of individuals achieved HDV RNA that was undetectable compared with 70% in the 10 mg group.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JULY 7, 2024
How do independent physicians’ practices maintain a data-based marketing strategy while staying HIPAA compliant? The post New Online Tracking Guidance from HHS: Staying Compliant While Not Breaking the Bank appeared first on MedCity News.
MedCity News
JULY 7, 2024
In addition to making suicide screening more accessible and widespread, successful implementation of safety plans is critical — here are 3 recommendations that care teams can implement. The post Safety Plans are Effective at Reducing Suicidal Behavior. So Why Aren’t More People Getting Them? appeared first on MedCity News.
Expert insights. Personalized for you.
115 
Let's personalize your content